BSEM SCHEDULE 13G: SEC filing
Andrew Van Vurst, an insider of BioStem Technologies
Filed with the SEC on · accession 0001213900-26-118034
BSEM filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -9.8% by the first close after the filing.
Summary of the filing
Andrew Van Vurst, an insider of BioStem Technologies, filed a Schedule 13G reporting beneficial ownership of 3,854,452 shares, or 18.4% of the company's common stock, as of September 30, 2026.
Key details
How BSEM stock reacted
Close before
$1.12
Nov 9, 2026
First close after
-9.82%
$1.01
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for BSEM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BSEM?
Click hereFrequently asked questions
What did BSEM file with the SEC on Nov 10, 2026?
BSEM filed a SCHEDULE 13G (SEC filing). Andrew Van Vurst, an insider of BioStem Technologies, filed a Schedule 13G reporting beneficial ownership of 3,854,452 shares, or 18.4% of the company's common stock, as of September 30, 2026.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did BSEM stock react to this filing?
BSEM closed at $1.12 before the filing and $1.01 on Nov 10, 2026 (-9.82%).
Other BSEM SEC filings
Get alerts when BSEM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days